Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial

Sun Jun 26 21:19:45 2022

(2015) Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial. Journal of Clinical Pharmacy and Therapeutics. pp. 441-446. ISSN 0269-4727

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

What is known and objectiveDepression is a debilitating complication of brucellosis and how best to treat this is a matter of debate. Inflammatory processes are involved in the pathogenesis of both brucellosis and depression. Therefore, we hypothesized that celecoxib could be beneficial for the treatment of depression due to brucellosis. MethodsForty outpatients with depression due to brucellosis with a Hamilton Depression Rating Scale score (HDRS) <19 participated in a randomized, double-blind, placebo-controlled trial and underwent 8weeks of treatment with either celecoxib (200mg bid) or placebo as an adjunctive to antibiotic therapy. Patients were evaluated using HDRS at baseline and weeks 4 and 8. Result and discussionRepeated-measures analysis demonstrated significant effect for time x treatment interaction on the HDRS score F (143, 5741)=3722, P<0001. Significantly greater response to treatment occurred in the celecoxib group than in the placebo group at the study end 10 patients (50%) vs. no patient (0%), respectively, P<0001. No serious adverse event was observed. What is new and conclusionCelecoxib is a safe and effective treatment for depression due to brucellosis when compared with placebo.

Item Type: Article
Creators:
CreatorsEmail
Jafari, S.UNSPECIFIED
Ashrafizadeh, S. G.UNSPECIFIED
Zeinoddini, A.UNSPECIFIED
Rasoulinejad, M.UNSPECIFIED
Entezari, P.UNSPECIFIED
Seddighi, S.UNSPECIFIED
Akhondzadeh, S.UNSPECIFIED
Keywords: brucellosis celecoxib clinical trial depression inflammation major depression add-on cardiovascular events clinical-trial schizophrenia disorder metaanalysis risperidone fluoxetine reboxetine Pharmacology & Pharmacy
Divisions:
Page Range: pp. 441-446
Journal or Publication Title: Journal of Clinical Pharmacy and Therapeutics
Journal Index: ISI
Volume: 40
Number: 4
Identification Number: https://doi.org/10.1111/jcpt.12287
ISSN: 0269-4727
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/558

Actions (login required)

View Item View Item